NCT01227408 2017-05-02
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
University of Southern California
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT00265733 2016-12-06
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00148707 2007-12-21
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed